老花眼矫正市场 - 调查报告(2025年)
市场调查报告书
商品编码
1751656

老花眼矫正市场 - 调查报告(2025年)

2025 Presbyopia Correction Survey Report

出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

MarketScope 首版 "老花眼矫正市场 - 研究报告 (2025)" 提供了关于老花眼治疗方法、采用计划、平均价格以及塑造老花眼格局的新兴技术的重要见解。从眼药水到老花眼矫正人工水晶体,本报告提供了重要的研究数据,有助于您在眼部保健领域做出明智的决策。无论您是医疗保健提供者、研究人员还是投资者,本报告都能帮助您自信地应对不断发展的老花眼市场。

目录

本报告基于来自眼科专业人士的广泛全球调查数据,深入分析了手术、药物和光学老花眼矫正方案。

主要亮点包括:

  • 治疗偏好:分析领先的老花眼管理策略(包括手术、药物和光学方案)。
  • 人工水晶体市场动态:製造商平均价格趋势、各品牌市场占有率以及术后可调节和中期优化人工水晶体的未来采用计划。
  • 屈光手术洞察:预测单视采用率、针对老花眼的LVC手术的单眼价格以及2025年的销售量。
  • 药物开发:预测Vuity和Qlosi等眼药水的患者人口统计和处方趋势,以及Lenz Therapeutics和Tenpoint Therapeutics即将推出的疗法的认知度和采用趋势。
  • 眼镜市场概览:视力矫正市场占有率、品牌占有率、更换计画以及眼镜、阅读器和隐形眼镜的购买频率。
  • 决策推动因素:哪些因素推动或减缓了新眼药水、隐形眼镜和手术技术在现实世界中的应用?
简介目录

Market Scope's first-edition "2025 Presbyopia Survey Report" provides pivotal insights into treatment methods, adoption plans, average pricing, and emerging technologies shaping the presbyopia landscape. From drops to presbyopia-correcting IOLs, this report delivers survey data essential for informed decision-making in ophthalmic care. Whether you're a healthcare provider, researcher, or investor, leverage this report to navigate the evolving presbyopia market with confidence.

Contents:

Based on extensive global survey data from ophthalmic professionals, this report provides deep insights across surgical, pharmaceutical, and optical presbyopia correction options.

Key highlights include:

  • Treatment Preferences: Analysis of primary presbyopia management strategies, including surgical, pharmaceutical, and optical options.
  • IOL Market Dynamics: Trends in average manufacturer pricing, market share by brand, and future adoption plans for post-op adjustable and intermediate-optimized IOLs.
  • Refractive Surgery Insights: Monovision selection rates, per-eye fees for LVC procedures targeting presbyopia, and volume expectations for 2025.
  • Pharmaceutical Developments: Patient demographics and prescribing trends for drops like Vuity and Qlosi, plus awareness and adoption projections for upcoming therapies from Lenz Therapeutics and Tenpoint Therapeutics.
  • Optical Market Overview: Share of vision correction across glasses, readers, and contacts-plus brand market share, replacement schedules, and frequency of purchases.
  • Decision Drivers: What drives-or delays-adoption of new drops, lenses, and surgical technologies in real-world practice.